A Novel Dietary-Related Model of Esophagitis and Barrett's Esophagus, a Premalignant Lesion

Abstract Barrett's esophagus (BE) is a premalignant lesion in which columnar epithelium (containing goblet cells) replaces esophageal squamous cells. Previous evidence suggested that hydrophobic bile acids and zinc deficiency each play a role in BE development. We fed wild-type C57BL/6 mice a zinc-deficient diet containing the hydrophobic bile acid, deoxycholic acid for various times up to 152 days. All mice fed this diet developed esophagitis by 69 days on the diet and 63% of the mice on this diet for 88 to 152 days also developed a BE-like lesion. Esophageal tissues showed thickened mucosa, increased proliferation, and increased expression of markers associated with oxidative and nitrosative stress. The newly formed BE-like lesions expressed Mucin-2, a marker of columnar differentiation. They also showed translocation of the p65 subunit of nuclear factor-κB and β -catenin to the nucleus and typical histological changes associated with BE lesions. This mouse model of esophagitis and BE is expected to contribute to a deeper understanding of BE pathogenesis and to strategies for prevention of BE progression to cancer.

[1]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[2]  A. Keshavarzian,et al.  Reactive oxygen species: are they involved in the pathogenesis of GERD, barrett's esophagus, and the latter's progression toward esophageal cancer? , 2002, American Journal of Gastroenterology.

[3]  T. Hattori,et al.  Immunohistochemical analysis of short‐segment Barrett's esophagus , 2004, Journal of gastroenterology and hepatology.

[4]  H. Çelik,et al.  Effect of omeprazole on plasma zinc levels after oral zinc administration. , 2002, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[5]  F. Bosman,et al.  Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett esophagus. , 2000, American journal of clinical pathology.

[6]  R. Sampliner,et al.  A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. , 1999, Cancer research.

[7]  M. Monden,et al.  Beta-catenin expression in human cancers. , 1996, The American journal of pathology.

[8]  J. Peters,et al.  Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids , 2007, Journal of Gastrointestinal Surgery.

[9]  J. Beynon,et al.  Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity , 1999, Gut.

[10]  G. Triadafilopoulos,et al.  Acid- and bile-induced PGE2 release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-ε dependent , 2002 .

[11]  J. Dekker,et al.  Gastric‐type mucin and TFF‐peptide expression in Barrett's oesophagus is disturbed during increased expression of MUC2 , 2003, Histopathology.

[12]  Y. Doki,et al.  Cytoplasmic β‐catenin in esophageal cancers , 1999 .

[13]  F. Real,et al.  Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. , 1994, Gastroenterology.

[14]  H Feussner,et al.  Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease. , 1997, Surgery.

[15]  M. Klein,et al.  Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus , 2004, Laboratory Investigation.

[16]  P. Dítě,et al.  [Barrett's esophagus]. , 2000, Bratislavske lekarske listy.

[17]  J. Reynolds,et al.  Proinflammatory Cytokine and Nuclear Factor Kappa-B Expression along the Inflammation–Metaplasia–Dysplasia–Adenocarcinoma Sequence in the Esophagus , 2005, The American Journal of Gastroenterology.

[18]  B. Ames,et al.  Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFκB, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Croce,et al.  p53 deficiency accelerates induction and progression of esophageal and forestomach tumors in zinc-deficient mice. , 2003, Cancer research.

[20]  T. Jang,et al.  Expression of Inducible Nitric Oxide Synthase Is Increased in Rat Barrett's Esophagus Induced by Duodenal Contents Reflux , 2005, Journal of Korean medical science.

[21]  G. Cotter,et al.  Effects of captopril and enalapril on zinc metabolism in hypertensive patients. , 1998, Journal of the American College of Nutrition.

[22]  W. Maret,et al.  Zinc requirements and the risks and benefits of zinc supplementation. , 2006, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[23]  R. Sampliner,et al.  Abnormal Expression of Biomarkers in Incompletely Ablated Barrett’s Esophagus , 2006, Annals of surgery.

[24]  Z. Kelman.  PCNA: structure, functions and interactions , 1997, Oncogene.

[25]  Y. Doki,et al.  Cytoplasmic beta-catenin in esophageal cancers. , 1999, International journal of cancer.

[26]  Robert C. G. Martin,et al.  Esophageal injury with external esophageal perfusion. , 2005, The Journal of surgical research.

[27]  H. Steininger,et al.  Expression of CDX2 and MUC2 in Barrett's mucosa. , 2005, Pathology, research and practice.

[28]  H. Bernstein,et al.  Bile acids as carcinogens in human gastrointestinal cancers. , 2005, Mutation research.

[29]  J. Hagen,et al.  The impact of reflux composition on mucosal injury and esophageal function , 2006, Journal of Gastrointestinal Surgery.

[30]  J. Reynolds,et al.  NF-&kgr;B Activation in Esophageal Adenocarcinoma: Relationship to Barrett's Metaplasia, Survival, and Response to Neoadjuvant Chemoradiotherapy , 2004, Annals of surgery.

[31]  A. Cameron,et al.  Epidemiology of columnar-lined esophagus and adenocarcinoma. , 1997, Gastroenterology clinics of North America.

[32]  J. Beckman.  Oxidative damage and tyrosine nitration from peroxynitrite. , 1996, Chemical research in toxicology.

[33]  Steffen Mühldorfer,et al.  Activation of NFκB Represents the Central Event in the Neoplastic Progression Associated with Barrett's Esophagus: A Possible Link to the Inflammation and Overexpression of COX-2, PPARγ and Growth Factors , 2004, Digestive Diseases and Sciences.

[34]  R. Sampliner,et al.  Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett’s oesophagus , 2006, Gut.

[35]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[36]  G. Jenkins,et al.  The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro. , 2003, Carcinogenesis.

[37]  H. Bernstein,et al.  Mitochondrial perturbation attenuates bile acid-induced cytotoxicity , 2005, Cell Biology and Toxicology.

[38]  R. Mancini,et al.  Combined Cyclin D 1 Overexpression and Zinc Deficiency Disrupts Cell Cycle and Accelerates Mouse Forestomach Carcinogenesis 1 , 2003 .

[39]  C. Wild,et al.  Risk Factors, DNA Damage, and Disease Progression in Barrett's Esophagus , 2005, Cancer Epidemiology Biomarkers & Prevention.

[40]  F. Bosman,et al.  Beta-catenin expression and its association with prognostic factors in adenocarcinoma developed in Barrett esophagus. , 2002, American journal of clinical pathology.

[41]  A. Lindgren,et al.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.

[42]  H. Barr,et al.  Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. , 1998, The American journal of pathology.

[43]  S. Spechler,et al.  Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. , 2002, Gastroenterology.

[44]  J. Jankowski,et al.  Barrett's metaplasia , 2000, The Lancet.

[45]  D. Weisenburger,et al.  Nutrient Intakes and Adenocarcinoma of the Esophagus and Distal Stomach , 2002, Nutrition and cancer.

[46]  A. Baldwin,et al.  The NF-kappa B and I kappa B proteins: new discoveries and insights. , 1996, Annual review of immunology.

[47]  J. Pandolfino,et al.  Obesity: a challenge to esophagogastric junction integrity. , 2006, Gastroenterology.

[48]  M. Yılmaz,et al.  Increased oxidative stress and hypozincemia in male obesity. , 2002, Clinical biochemistry.

[49]  Ananda S. Prasad,et al.  Zinc in Cancer Prevention , 2009, Nutrition and cancer.

[50]  Webb Jl.  Nutritional effects of oral contraceptive use: a review. , 1980 .

[51]  Á. Lanas,et al.  Free radicals and antioxidant systems in reflux esophagitis and Barrett's esophagus. , 2005, World journal of gastroenterology.

[52]  Á. Lanas,et al.  Superoxide Anion and Nitric Oxide in High-Grade Esophagitis Induced by Acid and Pepsin in Rabbits , 2001, Digestive Diseases and Sciences.

[53]  K. Hahm,et al.  Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment. , 2001, Free radical biology & medicine.

[54]  M F Dixon,et al.  Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux? , 2001, Gut.

[55]  W. Leary,et al.  Urinary zinc excretion, diuretics, zinc deficiency and some side-effects of diuretics. , 1983, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[56]  H. Sandstead.  Understanding zinc: recent observations and interpretations. , 1994, The Journal of laboratory and clinical medicine.

[57]  J. Reynolds,et al.  Low pH induces co-ordinate regulation of gene expression in oesophageal cells. , 2006, Carcinogenesis.

[58]  E. Hahn,et al.  Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors. , 2004, Digestive diseases and sciences.

[59]  G. Triadafilopoulos,et al.  Acid- and bile-induced PGE(2) release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-epsilon dependent. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[60]  Robert C. G. Martin,et al.  Esophageal Injury with External Esophageal Perfusion1 , 2005 .